04.01.2014 Views

Broker-Dealer Litigation - Greenberg Traurig LLP

Broker-Dealer Litigation - Greenberg Traurig LLP

Broker-Dealer Litigation - Greenberg Traurig LLP

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Exchange Act and Section 17(a) of the Securities Act because there was an abundance of<br />

evidence that the defendants intentionally made deceptive contributions to the fraudulent<br />

scheme, despite the fact that the defendants did not actually prepare the financial statements or<br />

help to prepare the SEC filings. Alternatively, the court concluded that the defendants would be<br />

liable under an aiding and abetting theory of liability because their role in providing fake<br />

invoices in support of overstated revenue was integral to the fraudulent scheme.<br />

SEC v. Betta, Jr., 2011 WL 4369012 (S.D. Fla. Sept. 19, 2011).<br />

The SEC moved for summary judgment against defendant Gagliardi on its claims that he<br />

violated Section 17(a)(1) of the Securities Act and Section 10(b) of the Exchange Act. Gagliardi<br />

was a registered representative with Brookstreet Securities Corp. (“Brookstreet”), a broker-dealer<br />

and investment adviser that collapsed in June of 2007. The SEC alleged that Gagliardi<br />

recommended and sold collateralized mortgage obligations (“CMOs”) to customers even though<br />

he knew, or should have known, that the highly risky CMOs were unsuitable for these customers<br />

and he failed to disclose these risks. The court concluded that viewing the undisputed facts in a<br />

light most favorable to Gagliardi, there were genuine issues of material fact regarding whether<br />

Gagliardi acted with scienter and therefore, summary judgment was not appropriate.<br />

The SEC argued that Gagliardi’s failure to understand and adequately investigate the<br />

Program CMOs was an extreme departure from the standards of ordinary care to which brokers<br />

are held and that Gagliardi’s deviation from these standards of care presented such a clear danger<br />

of misleading his customers that he must have been aware of it. Gagliardi told his customers that<br />

CMOs were appropriate for retirees and that they were well-suited for the conservative segment<br />

of their investment portfolio because they were so safe. According to Gagliardi, he believed all<br />

of these representations because it was his understanding that the SEC and FINRA had “vetted<br />

and reviewed” Brookstreet’s CMO Program in the past and took no action. The court concluded<br />

that there were plausible opposing inferences that could be made from the evidence that did not<br />

lead to the conclusion, as a matter of law, that Gagliardi either knew or it was so obvious that he<br />

must have known that the Program CMOs were too risky and complex for certain investors. In<br />

light of the evidence presented regarding Brookstreet’s forms, training and approach to selling<br />

Program CMOs, the court concluded that as a matter of law, that it was not an extreme departure<br />

from the standard of ordinary care for Gagliardi to recommend CMOs as he had been trained.<br />

Additionally, Gagliardi submitted evidence that suggests that the risks associated with CMOs at<br />

the time was not so clearly established. Thus, the court denied the SEC’s motion for summary<br />

judgment on their Section 10(b) and Section 17(a)(1) claims.<br />

B.3<br />

56

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!